LEO Pharma appoints two divisional directors
pharmafile | March 25, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | LEO Pharma
LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.
Mike Williams (pictured) joins to head up the Dermatology Division and Barbara Reilly takes charge of the Thrombosis Division. Both appointments come after Geraldine Murphy took the helm as managing director last July.
Williams brings over 13 years’ experience from the pharma industry which he gained at Roche, AstraZeneca, Pfizer and Schering-Plough. “It is an exciting time to join LEO following the refocus of the organisation last October on building a global patient centric organisation”, he said.
Reilly moves into her new role from within LEO Pharma. She was previously Country manager for the Irish affiliate, and brings over 15 years of sales, marketing and commercial experience gained from across the business to the new UK/IE team.
“I am relishing the opportunity that lies ahead to lead the thrombosis team in an increasingly challenging and evolving market while utilising all our experiences to support the patients and stakeholders in both market places,” said Reilly.
In their new positions both will report to Geraldine Murphy, managing director. Commenting on her new directorate recruits, she said, “I am delighted to have both Mike and Barbara on board as we start 2013. They both bring extensive experience to our business and will be key to LEO UK & Ireland achieving our goals in both Dermatology and Thrombosis.”
Related Content
Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis
Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a …
LEO Pharma initiates phase 2a trial of delgocitinib cream for rare skin condition
LEO Pharma has initiated a phase 2a trial investigating delgocitinib cream in adults with mild-to-severe …
MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation in Great Britain …
